+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Point of Care & Rapid Diagnostics Market by Product Type, Technology, Test Type, End User, Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715637
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Point of Care & Rapid Diagnostics Market grew from USD 51.85 billion in 2024 to USD 55.61 billion in 2025. It is expected to continue growing at a CAGR of 7.13%, reaching USD 78.39 billion by 2030.

Setting the Stage for the Rapid Diagnostics Revolution

Point of care and rapid diagnostics have swiftly evolved from niche applications to indispensable tools in modern healthcare. Advances in miniaturization, automation, and connectivity have propelled these technologies to the forefront of clinical decision making, enabling faster, more accurate diagnoses across diverse care settings. This introduction examines the convergence of technological innovation, shifting care models, and patient-centric demands that underpin the remarkable momentum in this field.

Healthcare providers now prioritize tests that deliver actionable results within minutes, reducing time to treatment and improving outcomes. Simultaneously, regulatory frameworks and reimbursement policies have adapted to encourage decentralized testing, recognizing its potential to alleviate burdens on centralized laboratories. As we embark on this executive summary, we will map out the driving forces that are redefining the landscape and chart a course through the complex interplay of market dynamics, policy shifts, and emerging opportunities.

Evolving Dynamics Redefine Point of Care Diagnostics

The landscape of point of care and rapid diagnostics is being reshaped by several transformative shifts. Digital integration now connects devices directly to electronic health records, enabling seamless data flow and remote patient monitoring. Artificial intelligence is refining interpretation, reducing variability, and supporting clinicians with predictive insights. At the same time, home-based testing solutions are expanding, empowered by user-friendly interfaces and telehealth platforms that bridge gaps in access.

Regulatory agencies have responded to growing demand with accelerated pathways for approval, while value-based care models incentivize faster diagnosis and patient engagement. Supply chain resilience has also moved into focus, prompting stakeholders to evaluate local sourcing and onshoring strategies. In tandem, partnerships between diagnostics firms, technology providers, and healthcare systems are forging integrated platforms that promise to deliver comprehensive point of care solutions at scale.

Navigating the Ripple Effects of 2025 Tariff Policies

In 2025, new tariff measures imposed by the United States government have created significant reverberations throughout the point of care supply chain. Import duties on raw materials and finished diagnostic devices have elevated production costs for consumables such as reagents and test kits, while analyzers and readers incur additional levies that erode margin structures. Even data management software and support services have seen indirect cost pressures due to increased hardware expenses.

Manufacturers are navigating these headwinds by diversifying supplier networks and exploring tariff mitigation strategies, including domestic manufacturing partnerships and free trade zone utilization. Despite these efforts, diagnostic laboratories and end users face higher procurement prices that could be passed on to healthcare providers and patients. The cumulative effect underscores the importance of strategic sourcing and proactive policy engagement to maintain affordability and accessibility.

Segment-Specific Drivers Uncover Growth Opportunities

Market segmentation reveals distinct drivers and growth trajectories across product, technology, and end-user categories. Consumables, comprising reagents and test kits, lead in volume growth as routine checks and infectious disease screenings proliferate. Instrumentation demand is fueled by investments in analyzers and readers that deliver higher throughput and multiplexing capabilities, while software and services, from data management solutions to technical support, are gaining traction as stakeholders seek integrated ecosystems.

Technology pillars such as clinical chemistry and hematology continue to anchor traditional diagnostic workflows, even as immunoassay and molecular diagnostics expand into personalized medicine and pathogen surveillance. Test type diversity spans cardiac markers, coagulation assays, glucose monitoring systems, infectious disease panels, and fertility screenings, reflecting a broad clinical utility. End-user environments range from ambulatory care centers and clinics to diagnostic laboratories, home care settings, and hospitals, each with unique throughput requirements and adoption pressures. Applications straddle critical areas including cardiac care, coagulation testing, diabetes management, infectious disease diagnostics, oncology, and pregnancy testing. Distribution strategies vary from direct sales relationships to distributor networks, while digital platforms and online retail channels open new pathways for market penetration.

Regional Market Variations Shape Strategic Priorities

Regional dynamics inject further complexity into the point of care narrative. In the Americas, widespread healthcare digitization and robust reimbursement policies underpin strong adoption in both urban hospital centers and rural clinics. Cross-border regulatory harmonization within North America accelerates the deployment of next-generation diagnostic platforms, while Latin American markets prioritize cost-effective rapid tests to address public health challenges.

Europe, the Middle East & Africa present a mosaic of regulatory regimes and healthcare infrastructures. Western Europe’s advanced reimbursement frameworks support high-end analyzers and integrated solutions, whereas emerging economies in Eastern Europe and the Middle East focus on scalable, low-cost testing. In Africa, point of care diagnostics play a pivotal role in infectious disease control, with donor-funded programs driving localized manufacturing and distribution partnerships. Meanwhile, Asia-Pacific exhibits dual trends: mature markets in Japan and Australia adopt sophisticated molecular workflows, while Southeast Asia and India experience explosive growth in affordable rapid test kits and decentralized service models.

Competitive Landscape Illuminates Strategic Leaders

Competition in point of care diagnostics is characterized by both established industry giants and nimble innovators. Large corporations leverage expansive product portfolios that span consumables, instrumentation, and digital solutions, offering end-to-end platforms that cater to hospital systems and reference labs. These companies invest heavily in research collaborations, regulatory approvals, and global distribution networks to maintain leadership.

Conversely, specialized firms focus on breakthrough assays, point-of-care molecular platforms, and cloud-based analytics, carving out niches through agility and targeted partnerships. Strategic alliances between diagnostics developers and technology providers accelerate the integration of artificial intelligence and telehealth capabilities. As the market matures, competitive differentiation will hinge on value-added services, interoperability, and the ability to demonstrate meaningful clinical and economic outcomes.

Strategic Imperatives for Stakeholder Success

To thrive amid evolving market conditions, stakeholders should prioritize diversification of supply chains by engaging local and regional suppliers, thereby mitigating tariff exposures and logistical disruptions. Investing in digital integration will not only streamline workflows but also enhance the value proposition by enabling real-time data analytics and remote monitoring. Aligning product development roadmaps with emerging reimbursement policies and value-based care initiatives can unlock new revenue streams and reinforce adoption.

Focusing on high-growth segments-such as molecular diagnostics for infectious diseases and remote glucose monitoring-can yield disproportionate returns. Collaborating with clinicians, payers, and patient advocacy groups will ensure that innovative solutions meet unmet needs and secure market access. Finally, forging strategic partnerships that combine diagnostic expertise with software and service capabilities will position organizations to deliver comprehensive, end-to-end solutions that resonate with modern healthcare demands.

Robust Methodology Underpins Reliable Insights

This analysis is built upon a rigorous blend of primary and secondary research. Expert interviews with industry executives, laboratory directors, payers, and regulatory authorities provided firsthand perspectives on market drivers, challenges, and future directions. These qualitative insights were complemented by a comprehensive review of peer-reviewed journals, industry white papers, company filings, and government databases to ensure depth and accuracy.

Market segmentation and regional analyses were validated through triangulation methodologies, cross-referencing data points from multiple sources. Quantitative metrics were examined alongside case studies and pilot program results to assess real-world performance. Peer reviews and editorial oversight guaranteed methodological consistency and eliminated bias, reinforcing the reliability of the findings presented in this executive summary.

Synthesis of Insights and Forward-Looking Perspectives

The convergence of technological innovation, shifting regulatory frameworks, and evolving care delivery models positions point of care and rapid diagnostics at the forefront of healthcare transformation. Tariff policies in 2025 have introduced cost pressures that necessitate agile supply chain strategies and policy engagement. Detailed segmentation analysis underscores the diverse needs across products, technologies, test types, end users, applications, and distribution channels. Regional disparities highlight both mature market sophistication and emerging market potential, while competitive dynamics reveal opportunities for differentiation through integrated solutions and strategic partnerships.

As the market continues to evolve, stakeholders equipped with nuanced insights and proactive strategies will be best positioned to capitalize on growth opportunities. This executive summary offers a distilled yet comprehensive foundation for informed decision making, guiding leaders toward sustainable success in the rapidly advancing realm of point of care diagnostics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Consumables
      • Reagents
      • Test Kits
    • Instruments
      • Analyzers
      • Readers
    • Software & Services
      • Data Management Software
      • Support Services
  • Technology
    • Clinical Chemistry
    • Hematology
    • Immunoassay
    • Molecular Diagnostics
  • Test Type
    • Cardiac Markers
    • Coagulation
    • Glucose Monitoring
    • Infectious Diseases
    • Pregnancy & Fertility
  • End User
    • Ambulatory Care Centers
    • Clinics
    • Diagnostic Laboratories
    • Home Care Settings
    • Hospitals
  • Application
    • Cardiac Care
    • Coagulation Testing
    • Diabetes Management
    • Infectious Disease Diagnostics
    • Oncology
    • Pregnancy Testing
  • Distribution Channel
    • Direct Sales
    • Distributors
    • E-Commerce Platforms
    • Online Retail
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Quidel Corporation
  • Ortho Clinical Diagnostics GmbH
  • QIAGEN N.V.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Point of Care & Rapid Diagnostics Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Reagents
8.2.2. Test Kits
8.3. Instruments
8.3.1. Analyzers
8.3.2. Readers
8.4. Software & Services
8.4.1. Data Management Software
8.4.2. Support Services
9. Point of Care & Rapid Diagnostics Market, by Technology
9.1. Introduction
9.2. Clinical Chemistry
9.3. Hematology
9.4. Immunoassay
9.5. Molecular Diagnostics
10. Point of Care & Rapid Diagnostics Market, by Test Type
10.1. Introduction
10.2. Cardiac Markers
10.3. Coagulation
10.4. Glucose Monitoring
10.5. Infectious Diseases
10.6. Pregnancy & Fertility
11. Point of Care & Rapid Diagnostics Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Home Care Settings
11.6. Hospitals
12. Point of Care & Rapid Diagnostics Market, by Application
12.1. Introduction
12.2. Cardiac Care
12.3. Coagulation Testing
12.4. Diabetes Management
12.5. Infectious Disease Diagnostics
12.6. Oncology
12.7. Pregnancy Testing
13. Point of Care & Rapid Diagnostics Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. E-Commerce Platforms
13.5. Online Retail
14. Americas Point of Care & Rapid Diagnostics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Point of Care & Rapid Diagnostics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Point of Care & Rapid Diagnostics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Roche Diagnostics International AG
17.3.3. Siemens Healthineers AG
17.3.4. Danaher Corporation
17.3.5. Thermo Fisher Scientific Inc.
17.3.6. Becton, Dickinson and Company
17.3.7. bioMérieux SA
17.3.8. Quidel Corporation
17.3.9. Ortho Clinical Diagnostics GmbH
17.3.10. QIAGEN N.V.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. POINT OF CARE & RAPID DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. POINT OF CARE & RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 70. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 71. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 72. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 81. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 125. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 127. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 136. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 152. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 153. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 154. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 161. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 162. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 163. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 197. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 198. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 199. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 215. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 217. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 224. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 226. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 251. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 252. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 253. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 260. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 262. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 278. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 280. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 287. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 288. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 289. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND POINT OF CA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Point of Care & Rapid Diagnostics market report include:
  • Abbott Laboratories
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Quidel Corporation
  • Ortho Clinical Diagnostics GmbH
  • QIAGEN N.V.

Table Information